We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
+$641M
Cap. Flow
+$372M
Cap. Flow %
16.15%
Top 10 Hldgs %
31.4%
Holding
680
New
190
Increased
323
Reduced
69
Closed
28

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.6M
2
AOS icon
A.O. Smith
AOS
+$7.79M
3
JPM icon
JPMorgan Chase
JPM
+$7.71M
4
MSFT icon
Microsoft
MSFT
+$6.58M
5
BAC icon
Bank of America
BAC
+$6.05M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.15M
2
MD icon
Pediatrix Medical
MD
+$3.07M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$2.05M
4
W icon
Wayfair
W
+$1.83M
5
ARWR icon
Arrowhead Research
ARWR
+$1.69M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 15.48%
3 Consumer Discretionary 11.83%
4 Financials 11.36%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
526
Arrowhead Research
ARWR
$12.4B
$192K 0.01%
10,497
-102,189
-91% -$1.69M
CYBR
527
DELISTED
CyberArk
CYBR
$190K 0.01%
1,600
– –
PLAN
528
DELISTED
Anaplan, Inc.
PLAN
$189K 0.01%
4,800
– –
SRE icon
529
Sempra
SRE
$54.8B
$179K 0.01%
2,836
+374
+15% +$22K
ESTC icon
530
Elastic
ESTC
$7.81B
$178K 0.01%
+2,221
New +$186K
KIDS icon
531
OrthoPediatrics
KIDS
$595M
$178K 0.01%
+4,030
New +$153K
QRVO icon
532
Qorvo
QRVO
$8.74B
$178K 0.01%
2,479
+46
+2% +$3.05K
MYOK
533
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$176K 0.01%
3,378
+857
+34% +$39.5K
THO icon
534
Thor Industries
THO
$4.14B
$175K 0.01%
2,803
-216
-7% -$13.7K
PEG icon
535
Public Service Enterprise Group
PEG
$37.7B
$167K 0.01%
2,804
+414
+17% +$23.1K
FFIV icon
536
F5
FFIV
$22.7B
$162K 0.01%
1,032
-205
-17% -$33K
AYX
537
DELISTED
Alteryx Inc
AYX
$162K 0.01%
1,928
+50
+3% +$3.61K
DOX icon
538
Amdocs
DOX
$6.22B
$160K 0.01%
2,956
+130
+5% +$7.31K
OMC icon
539
Omnicom Group
OMC
$23.4B
$160K 0.01%
2,192
+512
+30% +$38.4K
STX icon
540
Seagate
STX
$184B
$160K 0.01%
3,341
-636
-16% -$28.2K
OPTU
541
Optimum Communications Inc
OPTU
$301M
$158K 0.01%
7,359
+1,159
+19% +$23.4K
DLR icon
542
Digital Realty Trust
DLR
$71.7B
$158K 0.01%
1,324
– –
DNTH icon
543
Dianthus Therapeutics
DNTH
$6.09B
$155K 0.01%
588
– –
FATE icon
544
Fate Therapeutics
FATE
$326M
$153K 0.01%
8,673
– –
EIDX
545
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$151K 0.01%
6,446
– –
SRPT icon
546
Sarepta Therapeutics
SRPT
$1.77B
$150K 0.01%
1,257
+252
+25% +$32.4K
ALRM icon
547
Alarm.com
ALRM
$2.85B
$149K 0.01%
2,288
+157
+7% +$9.52K
FOXA icon
548
Fox Class A
FOXA
$26.9B
$149K 0.01%
+4,046
New +$158K
INSM icon
549
Insmed
INSM
$28.6B
$145K 0.01%
+4,983
New +$129K
ARRY
550
DELISTED
Array Biopharma Inc
ARRY
$144K 0.01%
5,892
+3,925
+200% +$81.7K
20 21
22
23 24

Similar funds

TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
BA
Boston Advisors Boston, Massachusetts $1.91B AUM 6.26% 1-Year Est. Return

Tiverton Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Tiverton Asset Management held 680 positions worth $2.31B, up 38% from $1.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tiverton Asset Management deployed $372M of net new capital in Q1 2019, opening 190 new positions and adding to 323 existing holdings. Its largest new stake was Pfizer: 104,318 shares worth $4.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Celgene Corp, an estimated $7.15M trimmed.

  • Tiverton Asset Management's largest Q1 2019 buy was Pfizer: 104,318 shares worth $4.2M.
  • Tiverton Asset Management added most to Alphabet (Google) Class A in Q1 2019, an estimated $9.6M increase.
  • Tiverton Asset Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $7.15M.
  • Tiverton Asset Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $1.07M.
  • Tiverton Asset Management's ten largest holdings make up 31% of its $2.31B portfolio in Q1 2019.
  • Tiverton Asset Management opened 190 new positions and closed 28 in Q1 2019.
  • Tiverton Asset Management's portfolio value rose 38% quarter-over-quarter to $2.31B.

Based on Tiverton Asset Management's 13F filing for Q1 2019, filed 13 May 2019.